rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5 Pt 2
|
pubmed:dateCreated |
1996-8-15
|
pubmed:abstractText |
Only a few cases of essential thrombocythemia in pregnant women have been reported, and the management of this myeloproliferative disorder during pregnancy remains uncertain. We report a successful pregnancy in a patient who had essential thrombocythemia and who was treated with interferon-alpha, and we review the literature for the outcome of similar patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0029-7844
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
87
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
814-7
|
pubmed:dateRevised |
2009-10-26
|
pubmed:meshHeading |
pubmed-meshheading:8677098-Adult,
pubmed-meshheading:8677098-Aspirin,
pubmed-meshheading:8677098-Female,
pubmed-meshheading:8677098-Humans,
pubmed-meshheading:8677098-Infant, Newborn,
pubmed-meshheading:8677098-Interferon-alpha,
pubmed-meshheading:8677098-Male,
pubmed-meshheading:8677098-Platelet Aggregation Inhibitors,
pubmed-meshheading:8677098-Pregnancy,
pubmed-meshheading:8677098-Pregnancy Complications, Hematologic,
pubmed-meshheading:8677098-Pregnancy Outcome,
pubmed-meshheading:8677098-Thrombocythemia, Essential
|
pubmed:year |
1996
|
pubmed:articleTitle |
Treatment of essential thrombocythemia during pregnancy with interferon-alpha.
|
pubmed:affiliation |
Saint-Sacrement Hospital, Laval University, Quebec, Canada.
|
pubmed:publicationType |
Journal Article,
Review,
Case Reports
|